Pharmaceutical News and Articles

Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use

MONDAY, May 4, 2026 New research is raising alarms about inhalants, which are often portrayed online as harmless while putting teens at real risk. Two new studi

Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds

MONDAY, May 4, 2026 Misinformation is putting more than 16 million Americans at increased risk for skin cancer, a new American Academy of Dermatology (AAD) surv

Patients Wait About 50 Days on Average for First Visit to Neurologist

Wait times for new neurologist appointments are about 50 days on average and vary by sex, neurologic conditions, and insurance type and geographic-level variabl

ASBrS: Robotic Nipple-Sparing Mastectomy Safe, Effective in Early Breast Cancer

For patients with early-stage breast cancer, robotic nipple-sparing mastectomy (rNSM) is as safe and effective as open NSM, according to a study presented at th

Continuous Glucose Monitoring Improves Blood Glucose Control in Type 2 Diabetes

Real-time continuous glucose monitoring (CGM) improves blood glucose management in adults with type 2 diabetes managed with basal insulin, according to a study

HRS: Atrial Arrhythmia Recurrence Lower in Persistent A-Fib With Pulsed Field Ablation Versus Antiarrhythmics

For patients with persistent atrial fibrillation, receipt of pulsed field ablation (PFA) is associated with a significantly lower risk for recurrence of atrial

Maternal RSV Vaccination, Infant Nirsevimab Immunization Safe, Effective

Maternal respiratory syncytial virus (RSV) vaccination and infant nirsevimab immunization, administered alone or sequentially, are safe and effective, according

FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib

MONDAY, May 4, 2026 The U.S. Food and Drug Administration (FDA) granted expanded access for the use of an experimental pancreatic cancer drug, daraxonrasib. Thi

Incyte Announces FDA Approval of Jakafi XR (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease

Adding Weekly GLP-1 to Cognitive Behavioral Therapy Further Reduces Heavy Drinking

A team of National Institutes of Health (NIH) scientists and international colleagues have reported the first evidence from a randomized controlled clinical tri